Lack of psychotropic medication changes among mood disordered women across the peripartum period.

ABSTRACT:

Objective

Peripartum depression is a leading contributor to peripartum morbidity and mortality. Despite the evidence for relative safety, many patients and providers remain reluctant to use or modify psychotropics in the peripartum period. We hypothesized that depressed women in the peripartum period taking psychiatric medications would not experience dose adjustments.

Methods

Women with a prior history of either Major Depressive Disorder or Bipolar Affective Disorder were followed through pregnancy and the postpartum period (N = 229). Depressive symptoms were measured with the Edinburgh Postnatal Depression Scale (EPDS), with a score ≥ 13 indicating likely depression. Data analysis included descriptive statistics, chi-square tests, and logistic regression.

Results

An

SUBMITTER: Standeven LR 

PROVIDER: S-EPMC8416692 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature